Review portfolio at every major life event

By Atul Shinghal

How you invest and where you invest are two factors that define whether you will be able to achieve your financial goals within the stipulated timeline. Balancing risk and growth when selecting an investment style depends on several key factors.

Financial goals

Your financial goals are a key factor in determining your investment style. Short-term goals (1–3 years) may require a more conservative approach, while long-term goals (10+ years) can often accommodate more risk. For example, a home purchase in 5–7 years may call for a moderate approach, children’s education in the next 10–15 years might require a moderate-to-aggressive strategy, and retirement planning over 20+ years can start with an aggressive approach for younger investors, becoming more conservative as retirement approaches.

Also Read ‘In 2025, take the middle path through diverse investments’ What will drive stocks in 2025? Budget, earnings, and more Stick with diversified equity funds, avoid sectoral funds now: PPFAS Mutual Fund CIO Rajeev Thakkar 6 high growth sectors to watch for maximum investment returns in 2025

Understanding your risk appetite is equally crucial for selecting the right investment style. For instance, a conservative portfolio might allocate 15–20% to equities, 60–70% to fixed income, 5–7% to alternatives, and 0–5% to cash. On the other hand, an aggressive portfolio would allocate 60–70% to equities, 10–15% to fixed income, 5–10% to alternatives, and 0% to cash.

Also ReadDebt funds flock to state bonds Time horizon

The time horizon also plays a significant role. Longer horizons allow for more aggressive strategies, as there’s more time to recover from market downturns. As your time horizon shortens, it’s wise to shift towards a more conservative allocation to protect your gains.

Additionally, your current financial situation—income stability, existing assets and liabilities, and emergency fund considerations—should inform your investment style. Those with stable incomes and strong financial foundations may take on more risk, while those with less predictability should be cautious.

Remember, your investment style should evolve as your circumstances change. Conduct a thorough review of your portfolio at least annually, or when significant life events occur, such as marriage, the birth of a child, or a job change. To rebalance, you can gradually adjust your asset allocation by selling some investments and purchasing others to maintain your desired risk level.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth